AU2020901738A0 - Superior treatment of the COVID-19 virus - Google Patents

Superior treatment of the COVID-19 virus

Info

Publication number
AU2020901738A0
AU2020901738A0 AU2020901738A AU2020901738A AU2020901738A0 AU 2020901738 A0 AU2020901738 A0 AU 2020901738A0 AU 2020901738 A AU2020901738 A AU 2020901738A AU 2020901738 A AU2020901738 A AU 2020901738A AU 2020901738 A0 AU2020901738 A0 AU 2020901738A0
Authority
AU
Australia
Prior art keywords
covid
virus
superior treatment
superior
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2020901738A
Inventor
Terry Fortescue Croft
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Croft Infrastructure Designs Pty Ltd
Original Assignee
Croft Infrastructure Designs Pty Ltd
Filing date
Publication date
Application filed by Croft Infrastructure Designs Pty Ltd filed Critical Croft Infrastructure Designs Pty Ltd
Publication of AU2020901738A0 publication Critical patent/AU2020901738A0/en
Priority to PCT/AU2021/050515 priority Critical patent/WO2021237299A1/en
Priority to US17/927,269 priority patent/US20230201149A1/en
Priority to CN202180059537.3A priority patent/CN116234563A/en
Priority to EP21811848.7A priority patent/EP4157251A1/en
Priority to AU2021280407A priority patent/AU2021280407A1/en
Assigned to CROFT INFRASTRUCTURE DESIGNS PTY LTD reassignment CROFT INFRASTRUCTURE DESIGNS PTY LTD Amend patent request/document other than specification (104) Assignors: CROFT INFRASTRUCTURE DESIGNS PTY LTD
Abandoned legal-status Critical Current

Links

AU2020901738A 2020-05-27 2020-05-27 Superior treatment of the COVID-19 virus Abandoned AU2020901738A0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
PCT/AU2021/050515 WO2021237299A1 (en) 2020-05-27 2021-05-27 Methods of antipathogenic treatment
US17/927,269 US20230201149A1 (en) 2020-05-27 2021-05-27 Methods of antipathogenic treatment
CN202180059537.3A CN116234563A (en) 2020-05-27 2021-05-27 Anti-pathogenic therapeutic methods
EP21811848.7A EP4157251A1 (en) 2020-05-27 2021-05-27 Methods of antipathogenic treatment
AU2021280407A AU2021280407A1 (en) 2020-05-27 2021-05-27 Methods of antipathogenic treatment

Publications (1)

Publication Number Publication Date
AU2020901738A0 true AU2020901738A0 (en) 2020-06-11

Family

ID=

Similar Documents

Publication Publication Date Title
EP3846846A4 (en) Compositions and methods for the treatment of viral infections
EP3934652A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3976595A4 (en) Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
EP3474861A4 (en) Compositions comprising hmos, their production and use for the prevention and/or treatment of viral and/or bacterial infections
EP3577124A4 (en) Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus
EP4025256A4 (en) Compositions and methods for the treatment of viral infections
EP3906043A4 (en) Methods and compositions for the treatment of fabry disease
EP3969597A4 (en) Compositions and methods for the treatment of atpase-mediated diseases
EP4031120A4 (en) Treatment of syngap1 encephalopathy
EP3982994A4 (en) Compositions and methods for the treatment of respiratory syncytial virus
EP3911160A4 (en) Treatment of plants against disease
EP3820492A4 (en) Apmv and uses thereof for the treatment of cancer
EP3820477A4 (en) Compounds, compositions, and methods for the treatment of disease
EP3710015A4 (en) Use of srsf3 agents for the treatment and/or prevention of neurological conditions, cancer, bacterial infections or viral infections
AU2020901738A0 (en) Superior treatment of the COVID-19 virus
EP3934632A4 (en) Esketamine for the treatment of depression
EP4065106A4 (en) Methods of treating hiv-1 infection
EP4041275A4 (en) Treatment and prevention of nephrotoxin-induced kidney injuries
EP4037707A4 (en) Compounds for the treatment of human immunodeficiency virus
EP3768681A4 (en) INHIBITION OF nSMase FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS INFECTION
EP3979789A4 (en) Treatment of saprolegniasis
EP4034125A4 (en) Treatment of excitotoxicity-related conditions
AU2019903588A0 (en) Treatment of excitotoxicity-related conditions
AU2019902149A0 (en) Antibody-Drug-Conjugates And Uses Thereof For The Treatment Of Cancer
AU2023900260A0 (en) Compounds for the treatment of viruses